Additionally, the transmembrane protein CD147 inhibits the p53-dependent signaling pathway via MCT1, promoting the reprogramming of glucose metabolism and cell proliferation in HCC cells (56). The gene discussed is SLC16A1; the disease is hepatocellular carcinoma.